<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Interferon therapy in clinical evaluation in SARS-CoV-2 infection (July 20, 2020).</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Biological treatment</bold>
    </th>
    <th valign="top" align="center" rowspan="1" colspan="1">
     <bold>Study identifier number, locations</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta, cholchicine, rivaroxaban, aspirin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04331899, Canada</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta, remdesivir, chloroquine, hydroxychloroquine, lopinavir/ritonavir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ISRCTN83971151 (Solidarity), WHO, multi-country clinical trial</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta1a, hydroxychloroquine, lopinavir/ritonavir, remdesivir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04315948 (DisCoVeRy), multi-centre (Europe)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta1a</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04385095, UK</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04350671 (IB1aIC), Iran</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04350684 (UAIIC), Iran</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-beta1b, hydroxychloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04350281, Hong Kong</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alfa (aerosols), lopinavir/ritonavir, traditional Chinese medicines</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04251871, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Recombinant human IFN-alpha1b</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000030480, China </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha aerosol inhalation, lopinavir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000030535, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha, ribavirin, lopinavir/ritonavir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000029387, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha atomization, lopinavir/ritonavir, favipiravir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000029600, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha, traditional Chinese medicine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000029756, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha aerosol/lopinavir/ritonavir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000031196, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">IFN-alpha2b, tocilizumab, losartan, remdesivir, hydroxychloroquine + combinations, methylprednisolone, convalescent serum</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04349410 (FMTVDM), SUA</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Recombinant human IFN-alpha 1b</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000030922, China </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Recombinant human IFN-alpha-1b (nasal drops)/thymosin alpha 1</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04320238, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">PegIFN-α2b atomization, arbidol hydrochloride</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04254874, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Long-acting IFN-alpha2a plus ribavirin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ChiCTR2000030922, China</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">PegIFN-lambda-1a</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04331899, SUA</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">PegIFN-lambda1a</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04354259 (ILIAD), Canada</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">PegIFN-lambda1a</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NCT04344600, (PROTECT), SUA</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">HeberFERON (recombinant IFN-α2b and IFN-γ, Heberon alfa (IFN-alfa2b)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">RPCEC00000307, Cuba</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Resources: U.S. National Library of Medicine 
   <uri xlink:type="simple" xlink:href="https://clinicaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov</uri>, International Clinical Trials Registry.
  </p>
  <p>Platform (ICTRP) 
   <uri xlink:type="simple" xlink:href="https://www.who.int/ictrp/en/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/ictrp/en/</uri>, Cochrane database (
   <uri xlink:type="simple" xlink:href="https://covid-nma.com/treatment_mapping/" xmlns:xlink="http://www.w3.org/1999/xlink">https://covid-nma.com/treatment_mapping/</uri>), Chinese Clinical Trial Registry (
   <uri xlink:type="simple" xlink:href="http://www.chictr.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org</uri>).
  </p>
 </table-wrap-foot>
</table-wrap>
